1. AB0497 IMPACT OF COXITIS ON THE BONE MINERAL DENSITY OF THE HIP IN ANKYLOSING SPONDYLITIS
- Author
-
M. Ezzeddine, Z. Gassara, A. Feki, M.H. Kallel, I. Sellami, H. Fourati, S. Ben Jemaa, Rim Akrout, and Soufiene Baklouti
- Subjects
Bone mineral ,Ankylosing spondylitis ,Rheumatology ,business.industry ,Immunology ,Immunology and Allergy ,Dentistry ,Medicine ,business ,medicine.disease ,General Biochemistry, Genetics and Molecular Biology - Abstract
Background:Ankylosing spondylitis (AS) is an inflammatory disease, with new bone formation and ossification of the ligamentous apparatus as the primary pathological changes. The osteoporosis is coexisting with new bone formation. It is well known a common complication of this chronic disease. Hip involvement is common in AS [1].Objectives:The objective of this work is to assess the impact of chronic inflammation of the hip (coxitis) on the bone density at this site.Methods:This is a cross-sectional study of patients who fulfil the modified New York criteria for AS. These patients had not medical history of osteoporosis or other condition that may affect bone metabolism. Hip involvement was appreciated by physical examination and pelvic x-ray. The functional hip gene was assessed by Lequesne Algofunctional Index (LFI). Bone mineral density at the femoral site was measured using Lunar Prodigy dual-energy X-ray absorptiometry. Osteoporosis is defined when T score is ≤ -2.5 DS (standards deviations). Osteopenia is defined when T score is ≤ -1 DS but more than -2.5 DS. A p value Results:Forty-seven AS patients were collected, 12 women and 35 men with a mean age of 43.8 ± 13.4 years. Smoking was noted in 25% of cases. AS clinical form was axial in 33 cases (70.2%) and mixed (axial and peripheral) in 14 cases (29.8%). The mean duration of AS was 15 ± 10.9 years. Nineteen patients (40.4%) were on DMARD at the time of the study. Coxitis was present in 31 patients (66%). It was bilateral in 13 cases (42.5%). The mean of the LFI was 7.1 ± 6.5 with extremes of 0 to 18. Coxitis form was early in 18 cases (40.9%), synostosis in 15 cases (34.1%) and destructive in 11 cases (25%). Twenty-nine patients (61.7%) had normal femoral bone densitometry, 13 patients (27.7%) had osteopenia and 4 patients (8.5%) had osteoporosis. The mean T-score value at femoral neck site was -0.5 SD ± 1.303 [-3– -2]. Patients with coxitis had a significantly lower T score at the femoral site compared to those without coxitis (-0.77 ± 1.31 DS versus 0.07 ± 1.11 DS respectively with p = 0.036).Conclusion:Our study confirms the role of chronic inflammation in the genesis of bone loss in AS. Given the risks of developing secondary complications as a result of low bone density, early management of AS should be recommended in order to control the inflammatory process and prevent the onset of osteoporosis.References:[1]Toussirot E, Wendling D. Bone mass in ankylosing spondylitis. Clin Exp Rheumatol 2000:16–20.Disclosure of Interests:None declared.
- Published
- 2021
- Full Text
- View/download PDF